WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001032193) CYTOTOXIC T LYMPHOCYTE-STIMULATING PEPTIDES FOR PREVENTION, TREATMENT, AND DIAGNOSIS OF MELANOMA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/032193    International Application No.:    PCT/US2000/029679
Publication Date: 10.05.2001 International Filing Date: 27.10.2000
Chapter 2 Demand Filed:    29.05.2001    
IPC:
A61K 38/00 (2006.01), A61K 39/00 (2006.01), C07K 14/47 (2006.01)
Applicants: ARGONEX PHARMACEUTICALS [US/US]; Suite 1, 706 Forest Street, Charlottesville, VA 22903 (US)
Inventors: HOGAN, Kevin, T.; (US).
ROSS, Mark, H.; (US).
SLINGLUFF, Craig, L.; (US)
Agent: GRANT, Alan, J.; Carella, Byrne, Bain, Gilfillan, Cecchi, Stewart & Olstein, 6 Becker Farm Road, Roseland, NJ 07068 (US)
Priority Data:
60/162,480 29.10.1999 US
Title (EN) CYTOTOXIC T LYMPHOCYTE-STIMULATING PEPTIDES FOR PREVENTION, TREATMENT, AND DIAGNOSIS OF MELANOMA
(FR) PEPTIDES STIMULANT LES LYMPHOCYTES T CYTOTOXIQUES, UTILISABLES EN PREVENTION, TRAITEMENT ET DIAGNOSTIC DE MELANOME
Abstract: front page image
(EN)The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, specifically malignant melanoma. The invention discloses peptides derived from one or more presently unidentified genes, as well as variants of these proteins that can be used to stimulate a CTL response against melanoma. Further disclosed, is a peptide derived from gp100, which can also be used to stimulate a CTL response against melanoma.
(FR)La présente invention concerne des procédés et compositions convenant à la prévention, au traitement et au diagnostic de cancer, et plus particulièrement de mélanomes malins. L'invention concerne également des peptides dérivés d'au moins un gène actuellement non identifié, ainsi que des variantes de ces protéines, lesquelles peptides et variantes conviennent à la stimulation de la réponse des lymphocytes T cytotoxiques contre les mélanomes. L'invention concerne enfin un peptide dérivé de gp100 convenant également à la stimulation de la réponse des lymphocytes T cytotoxiques contre les mélanomes.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)